SCHEMBL19837795

SCHEMBL19837795

COc1ccc(-c2csc(NC(=O)C3CCCN3C(=O)O)n2)cc1OC

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MEN1 O00255 8/20 0.61
KMT2A Q03164 8/20 0.61
MAPK1 P28482 3/20 0.61
ALDH1A1 P00352 2/20 0.61
ALOX15 P16050 1/20 0.61
HSD17B10 Q99714 1/20 0.61
KCNQ1 P51787 6/20 0.60
POLB P06746 4/20 0.58
HPGD P15428 1/20 0.55
KDM4E B2RXH2 1/20 0.55
NPSR1 Q6W5P4 1/20 0.55
RXFP1 Q9HBX9 1/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
MAPT P10636 2/20 0.54
LMNA P02545 1/20 0.52
HTT P42858 1/20 0.52
SMN1; SMN2 Q16637 1/20 0.52
P2RX3 P56373 1/20 0.52
NR2F2 P24468 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18029515 0.89 MEN1 (0.57) MEN1KMT2AMAPK1ALDH1A1ALOX15
SCHEMBL13524044 0.86 MEN1 (0.62) MEN1KMT2AMAPK1ALDH1A1ALOX15
SCHEMBL3143723 0.86 MEN1 (0.62) MEN1KMT2AMAPK1ALDH1A1ALOX15
SCHEMBL4723829 0.82 CNR2 (0.68) MEN1KMT2AALDH1A1HSD17B10KCNQ1
SCHEMBL13256798 0.81 KCNQ1 (0.65) MEN1KMT2AALDH1A1HSD17B10KCNQ1
SCHEMBL4724306 0.79 KCNQ1 (0.55) MEN1KMT2AALDH1A1HSD17B10KCNQ1
SCHEMBL13523983 0.79 MEN1 (0.59) MEN1KMT2AALDH1A1KCNQ1KDM4E
SCHEMBL13524107 0.79 MEN1 (0.59) MEN1KMT2AALDH1A1KCNQ1KDM4E
SCHEMBL3129451 0.79 MEN1 (0.59) MEN1KMT2AALDH1A1KCNQ1KDM4E
SCHEMBL3144912 0.79 MEN1 (0.59) MEN1KMT2AALDH1A1KCNQ1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180037556-A1 COMPOUNDS AND METHODS FOR INDUCING BROWNING OF WHITE ADIPOSE TISSUE BEIJING ERAI THERAPEUTICS CO., LTD. (CN) 2018-02-08 US claimed
CN-107635981-B Compounds and methods for inducing browning of white adipose tissue 中国科学院广州生物医药与健康研究院 2020-08-04 CN disclosed
US-20180037556-A1 COMPOUNDS AND METHODS FOR INDUCING BROWNING OF WHITE ADIPOSE TISSUE BEIJING ERAI THERAPEUTICS CO., LTD. (CN) 2018-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180037556-A1 COMPOUNDS AND METHODS FOR INDUCING BROWNING OF WHITE ADIPOSE TISSUE FABP4, LRBA, GPR119 MEN1 3965/4885KMT2A 2404/4885MAPK1 2199/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.